Scientist.com

Less than 24 hours away ⏳ This webinar featuring scientists from Lonza will cover practical examples and strategies for using cell-based assays to assess immune activation, offering actionable insights for advancing cancer immunotherapy development. Key topics include: - Understanding variety of cell-based assays used in immunogenicity testing - Donor considerations in design of these assays - Application trends in Immuno-oncology Register here: https://lnkd.in/grKPzrxu

How does NMA enhance comparative effectiveness research, inform healthcare policies, and drive optimized patient outcomes in an evolving treatment landscape? Watch this on-demand webinar for an in-depth exploration of NMA methodologies, practical applications and real-world impact. Attendees will engage with case studies and gain hands-on experience using R packages such as netmeta and multinma, equipping them with practical skills to conduct and interpret NMAs effectively. Watch it now: https://bit.ly/43HkvIL

🎙️ A sneak peek at the latest episode of the DPW podcast featuring Dan Kagan, President and COO of Scientist.com and Joe Carvalho, Head of Procurement, Biomedical Research at Novartis as they discuss the transformation of R&D procurement and how we've helped Novartis increase speed and efficiency within their procurement processes. Watch the full interview here: https://lnkd.in/gZVFvm3e DPW | Certified B Corp #DPWNewYork #PutAIToWork

Insights from an independent lab auditor 💭 Recently, Meaghan Loy, MS, ALAT sat down with Sandra Burlock, an independent lab auditor in the life sciences, to discuss her experience conducting assessments as part of the VERIF.i® program and how it's streamlining the pre-assessment process, changing the game for both suppliers and biopharmaceutical companies. Read the blog post or listen to the interview: https://lnkd.in/gARu79mv

RAG pipelines are becoming the backbone of LLM-based applications — but how do you build one that actually works in production? Access Chris Petersen's recent presentation where he breaks down the end-to-end architecture of a modern RAG system - published here in our latest blog post: https://lnkd.in/gZQjzSqU

ICYMI ➡️ The Tumor Model Finder (TMF) has hit a major milestone! Thanks to our strategic partnership with XenoSTART, the TMF has now surpassed 10,000 searchable oncology models available on the platform. We've enriched our collection with hundreds of unique and high-demand XenoSTART models—backed by histologic analysis, DNA/RNA sequencing and in vivo drug sensitivity testing. 🔍 Explore our database of over 10,000 oncology models on the TMF: https://lnkd.in/gUNRz_3Y Read the full press release: https://lnkd.in/gH_UUJ83

Endotoxin contamination can significantly interfere with experimental outcomes, especially in immune-related or cytokine-sensitive assays. That's why Sino Biological, Inc. developed a line of endotoxin-free proteins to ensure accuracy and consistency of your experimental data. Read more about what endotoxins are and how they affect research outcomes as well as how Sino Biological guarantees endotoxin-free protein production in our latest blog post: https://lnkd.in/gVKrikCQ Access their supplier profile to view their available services on the Scientist.com platform here: https://lnkd.in/gxSZc6xC

In this on-demand webinar, Dr. Sandy Tretbar introduces CAR Finder Technology and shares practical strategies to improve mRNA-based CAR T cell screening and selection. Attendees will gain insights into the challenges of CAR selection and how emerging technologies are revolutionizing this process! Watch now: https://lnkd.in/g3vjmBq8 Lonza

Imagine the potential of your ideas if resources and workforce constraints no longer stood in your way? We had a great time discussing the applications of AI in preclinical research with expert speakers from Discovery Life Sciences, BioIVT, and Certis Oncology. In this session we covered: ▶️ Beyond Human Eyes: How AI Turned Routine H&Es from Qualitative to Quantitative Insights ▶️ Unlocking Precision Medicine with Visionaire™: 30+ Years of Curated Biospecimen Data ▶️ CertisOI Assistant™ – Optimizing Preclinical Cancer Model Selection with Agentic AI Now available on-demand! Find the recording here: https://lnkd.in/ge4YDAMx

The rise of digital pathology and image analysis through software has introduced new opportunities for high-throughput, objective quantification compared to traditional microscopy-based assessments. In this blog post, Applied Pathology Systems shares the differences between software-based image quantification and semiquantitative scoring by pathologists — and why their combination leads to more robust and reliable results. Read it now: https://lnkd.in/gaxUpSMh